心理社会支持干预对住院和门诊医疗环境中生存率影响的荟萃分析:106项随机对照试验
该荟萃分析纳入106项随机对照试验共40,280例患者,评估医疗环境中辅助性心理社会支持干预对生存的影响。结果显示,在87项报告离散时间数据的试验中,干预组生存可能性提高20%(OR=1.20,95%CI 1.09-1.31,p<0.001);在22项报告生存时间的试验中,生存概率提高29%(HR=1.29,95%CI 1.12-1.49,p<0.001)。明确促进健康行为的干预改善了生存,而主要关注社会或情感结局的干预未延长生命。
要点
- 心理社会支持干预可提高患者生存可能性,OR=1.20,HR=1.29。
- 明确促进健康行为的干预改善生存,仅关注社会情感结局的干预未延长生命。
- 疾病严重程度较高者生存获益较小,对照组接受健康信息/课程者效应较弱。
核心结论
- 心理社会行为支持干预促进患者动机/应对以参与健康行为,可改善生存。
- 主要关注社会或情感结局的干预未延长生命。
- HR数据提示心理社会干预改善生存,但与健康信息/课程效果相似,且疾病严重程度较高者效果较差。
研究设计与样本
- 研究类型:随机对照试验(RCT)的荟萃分析,检索1980年1月至2020年10月文献。
- 数据来源:Embase、Medline、Cochrane Library、CINAHL、Alt HealthWatch、PsycINFO、Social Work Abstracts和Google Scholar。
- 纳入106项RCT,共40,280例患者;平均年龄57.2岁,女性52%,男性48%。
- 患者疾病构成:心血管疾病42%,癌症36%,其他疾病22%。
- 至少2名评审员筛选文献、提取数据并评估研究质量。
主要发现
- 87项RCT报告离散时间数据,平均OR=1.20(95%CI 1.09-1.31,p<0.001),干预组生存可能性提高20%。
- 22项RCT报告生存时间,平均HR=1.29(95%CI 1.12-1.49,p<0.001),干预组生存概率提高29%。
- 明确促进健康行为的干预改善生存,无此主要焦点的干预未改善生存。
- 荟萃回归识别3个调节变量:对照组类型、患者疾病严重程度、研究偏倚风险。
- 对照组接受健康信息/课程加常规治疗者效果较弱;疾病严重程度较高者生存时间获益较小。
关键数值与推荐
- 离散时间数据:OR=1.20(95%CI 1.09-1.31,p<0.001),基于87项RCT。
- 生存时间数据:HR=1.29(95%CI 1.12-1.49,p<0.001),基于22项RCT。
- 调节变量:对照组类型、患者疾病严重程度、研究偏倚风险。
临床怎么用
- 在医疗环境中可考虑实施明确促进健康行为的心理社会支持干预以改善生存。
- 主要关注社会或情感结局的干预不宜以延长生存为主要目标。
- 对疾病严重程度较高的患者,心理社会支持干预的生存获益可能较小。
局限性
- 干预极少对人员和参与者设盲,对改善的期望未得到控制。
- 研究偏倚风险仍是数据解释的合理威胁。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hospitals, clinics, and health organizations have provided psychosocial support interventions for medical patients to supplement curative care. Prior reviews of interventions augmenting psychosocial support in medical settings have reported mixed outcomes. This meta-analysis addresses the questions of how effective are psychosocial support interventions in improving patient survival and which potential moderating features are associated with greater effectiveness. METHODS AND FINDINGS: We evaluated randomized controlled trials (RCTs) of psychosocial support interventions in inpatient and outpatient healthcare settings reporting survival data, including studies reporting disease-related or all-cause mortality. Literature searches included studies reported January 1980 through October 2020 accessed from Embase, Medline, Cochrane Library, CINAHL, Alt HealthWatch, PsycINFO, Social Work Abstracts, and Google Scholar databases. At least 2 reviewers screened studies, extracted data, and assessed study quality, with at least 2 independent reviewers also extracting data and assessing study quality. Odds ratio (OR) and hazard ratio (HR) data were analyzed separately using random effects weighted models. Of 42,054 studies searched, 106 RCTs including 40,280 patients met inclusion criteria. Patient average age was 57.2 years, with 52% females and 48% males; 42% had cardiovascular disease (CVD), 36% had cancer, and 22% had other conditions. Across 87 RCTs reporting data for discrete time periods, the average was OR = 1.20 (95% CI = 1.09 to 1.31, p < 0.001), indicating a 20% increased likelihood of survival among patients receiving psychosocial support compared to control groups receiving standard medical care. Among those studies, psychosocial interventions explicitly promoting health behaviors yielded improved likelihood of survival, whereas interventions without that primary focus did not. Across 22 RCTs reporting survival time, the average was HR = 1.29 (95% CI = 1.12 to 1.49, p < 0.001), indicating a 29% increased probability of survival over time among intervention recipients compared to controls. Among those studies, meta-regressions identified 3 moderating variables: control group type, patient disease severity, and risk of research bias. Studies in which control groups received health information/classes in addition to treatment as usual (TAU) averaged weaker effects than those in which control groups received only TAU. Studies with patients having relatively greater disease severity tended to yield smaller gains in survival time relative to control groups. In one of 3 analyses, studies with higher risk of research bias tended to report better outcomes. The main limitation of the data is that interventions very rarely blinded personnel and participants to study arm, such that expectations for improvement were not controlled. CONCLUSIONS: In this meta-analysis, OR data indicated that psychosocial behavioral support interventions promoting patient motivation/coping to engage in health behaviors improved patient survival, but interventions focusing primarily on patients' social or emotional outcomes did not prolong life. HR data indicated that psychosocial interventions, predominantly focused on social or emotional outcomes, improved survival but yielded similar effects to health information/classes and were less effective among patients with apparently greater disease severity. Risk of research bias remains a plausible threat to data interpretation.
引用
- Smith TB, Workman C, Andrews C, et al. Effects of psychosocial support interventions on survival in inpatient and outpatient healthcare settings: A meta-analysis of 106 randomized controlled trials. PLoS Med. 2021. PMID: 34003832. doi:10.1371/journal.pmed.1003595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。